Douglas A. Hamilton
Chief Executive Officer at METASTAT, INC.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Parimal Nathwani | M | - |
Vasomune Therapeutics, Inc.
 Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
| Frederick Pierce | M | 63 | 9 years | |
| Paul Billings | M | 71 | 7 years | |
| Rady Johnson | M | 63 | 30 years | |
| Niclas Stiernholm | M | - |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
| Meenu Chhabra Karson | F | 51 |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | 4 years |
| Michael Young | M | - |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
| Payal Sahni Becher | F | - | 27 years | |
| Meenu Karson | F | 52 |
Vasomune Therapeutics, Inc.
Vasomune Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Vasomune Therapeutics, Inc. operates as an early stage biopharmaceutical company. It develops medicines to harness the body’s ability to defend against illness by modifying cellular response to disease. The company is headquartered in Toronto, Canada. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Fred H. Mermelstein | M | 64 |
Paramount Capital Investments LLC
PolaRx Biopharmaceuticals
 PolaRx Biopharmaceuticals Miscellaneous Commercial ServicesCommercial Services Part of Swedish Orphan Biovitrum AB, PolaRx Biopharmaceuticals is a private company that manufactures TriOxide drugs for the treatment of leukemia and other cancers. The company is based in New York, NY. The company was founded by Fred H. Mermelstein, Peter Morgan Kash, Raymond P. Warrell. PolaRx Biopharmaceuticals was acquired by CTI BioPharma Corp., part of Swedish Orphan Biovitrum AB from June 27, 2023 on January 13, 2000 for $17.50 million. | 6 years |
| Jerome Zeldis | M | 74 | 3 years | |
| Richard Berman | M | 81 | 3 years | |
| Johan Spoor | M | 52 | 4 years | |
| Wyllie Cornwell | M | 76 | 23 years | |
| H. Philip Goodeve | M | 63 | 3 years | |
| Martin MacKay | M | 68 | 14 years | |
| Martin Driscoll | M | 65 | 2 years | |
| Joseph M. Danis | M | - | 10 years | |
| David Siegel | M | 61 | 3 years | |
| Michael Brown | M | 82 | 16 years | |
| Daniel Schneiderman | M | 46 | 6 years | |
| David Epstein | M | 65 | 2 years | |
| Patrick T. Mooney | M | 55 | 2 years | |
| Roger Leone | M | - | 14 years | |
| Dan G. Keller | M | 65 | - | |
| Timothy Rolph | M | 70 | 22 years | |
| Hugh M. Donnelly | M | - | - | |
| Carlos A. Schuler | M | - |
S.E.A. Medical Systems, Inc.
 S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | - |
| Christopher Scully | M | 53 | 20 years | |
| Pedro Lichtinger | M | 70 | 14 years | |
| Thomas G. Gant | M | - | 6 years | |
| David Simmons | M | 59 | 16 years | |
| Paulash Mohsen | M | - | 14 years | |
| Natasha Kehimkar | F | - | 16 years | |
| Liam Ratcliffe | M | 60 | 12 years | |
| James J. Dolan | M | - | - | |
| Jay T. Goodwin | M | - | - | |
| Patrick W. Fabian | M | 56 | 3 years | |
| Michael Berelowitz | M | 79 | 15 years | |
| Alexandra Pearce | M | - | 11 years | |
| Randy Brenner | M | 51 | 15 years | |
| Paul Dominowski | M | - | 13 years | |
| Randall Kaja | M | - | 15 years | |
| Ravi Srinivasan | M | - |
S.E.A. Medical Systems, Inc.
S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | - |
| Angela Hwang | F | 58 | 26 years | |
| Trudy Nichols | F | - |
S.E.A. Medical Systems, Inc.
S.E.A. Medical Systems, Inc. Medical SpecialtiesHealth Technology S.E.A. Medical Systems, Inc. develops medical devices that catch serious or life-threatening intravenous drug errors. It specializes in developing medical devices that catch serious or life-threatening intravenous drug errors before they harm patients. It has created a disruptive platform technology with life-saving product applications, allowing for the identification and characterization of medical solutions in real time. The firm offers IV Check that validates IV preparations and measures pharmacy returns to detect narcotic or scheduled drug diversion. The company was founded in October 2008 by James W. Bennett, Leo Matsiev and Michael J. Weickert and is headquartered in Emerald Hills, CA. | - |
| Sep Sarshar | M | 57 | 3 years | |
| Mark J. Gustavson | M | - | - | |
| Shankar Musunuri | M | 60 | 14 years | |
| Tariq Arshad | M | 54 | 12 years | |
| Yugal Kishor C. Sikri | M | 66 | 6 years | |
| Roxanne Lagano | F | 59 | - | |
| Elizabeth Buck | M | 49 | 1 years | |
| Shauna M. Tholen | F | - | 3 years | |
| Robert Sheroff | M | 69 | 7 years | |
| James Kuo | M | 58 | 2 years | |
| Beth Levine | F | 60 | 13 years | |
| Barbara-Jean Bormann-Kennedy | M | 65 | 11 years | |
| David L. Brinkley | M | 66 | - | |
| Franklin Raines | M | 74 | 3 years | |
| Ruth Simmons | M | 78 | 10 years | |
| Ken Keyong Ren | M | 64 | 2 years | |
| Walter S. Hauck | M | 64 | 13 years | |
| Jon Coleman | M | 60 | 12 years | |
| Peter Powchik | M | 67 | 5 years | |
| John W. Poyhonen | M | 64 | 7 years | |
| Peter S. Ringrose | M | 78 | 14 years | |
| Mary Winston | F | 62 | 7 years | |
| Martin Mattingly | M | 66 | 7 years | |
| Karen Dawes | F | 72 | 10 years | |
| Joshua Makower | M | 60 | - | |
| Dilip J. Mehta | M | 91 | 15 years | |
| Gerard G. Gorman | M | 73 | 5 years | |
| Charles A. Baker | M | 91 | 19 years | |
| Anthony P. Shuber | M | - | - | |
| Michael T. Sweeney | M | 63 | 8 years | |
| James New | M | 70 | 5 years | |
| Eliot Forster | M | 58 | 11 years | |
| George E. Stagnitti | M | - | 5 years | |
| Gill Eapen | M | - | 3 years | |
| Evan Myrianthopoulos | M | 59 |
Paramount Capital Investments LLC
| 2 years |
| Christopher S. Hassan | M | 63 | 4 years | |
| Lynne E. Weissberger | M | - | 7 years | |
| Michael Donovan | M | 70 | - | |
| Jonathan Treherne | M | 62 | - | |
| Feargal Mooney | M | 54 | 3 years | |
| David F. Fitzgerald | M | 90 | 26 years | |
| Albert Lee Rauch | M | - | 6 years | |
| Pat Parr | M | - | 6 years | |
| Margaret Foran | F | 69 | 11 years | |
| Mark A. Braman | M | - | 12 years | |
| Jonathan R. McGrath | M | - | 5 years | |
| Nazanine Scheuer | F | - | 9 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 88 | 94.62% |
| Canada | 5 | 5.38% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Douglas A. Hamilton
- Personal Network
